Clinical Epidemiology & Biostatistics


Salim Yusuf

MD (Bangalore), DPhil (Oxford), MRCP

Heart and Stroke Foundation of Ontario / Marion W. BUrke Chair in Cardiovascular Disease

Professor, Department of Medicine

Joint Member, Dept of Clinical Epidemiology & Biostatistics

Director, Population Health Research Institute

905.297.3781 
905.521.1166
yusufs@mcmaster.ca

McMaster University
Faculty of Health Sciences
Hamilton Health Sciences Corporation
General Site, McMaster Clinic
237 Barton St. E.
Hamilton, Ontario
L8L 2X2

Executive Assistant: Judy Lindeman
905.297.3781 
905.521.1166
judy.lindeman@phri.ca 

Academic Interests

Dr. Yusuf's recent interests include societal, biologic and genetic determinants of population health in developing populations, and his studies involve over 83 countries in all the inhabited continents of the world.

Current HRM Graduate Students
Denis Xavier
Richard Whitlock (PhD)

Recent HRM Graduate Students
G. Karthikeyan

Selected Publications

  1. Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA 2005; 293(4): 427-35.
  2. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293(4): 437-46.
  3. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9437): 937-52.
  4. Rosengren A, Hawken S, Ôunpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-amorn C, Sato H, Yusuf S for the INTERHEART investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9437): 953-62
  5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2003; 104(22): 2746-53.
  6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2003; 104(23): 2855-64.
  7. Yusuf S on behalf of the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of Clopidogrel in Addition to Aspirin in Patients with Non-ST Segment Elevation Acute Coronary. NEJM 2003;345:494-502.
  8. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. NEJM 2000;342:145-53.
  9. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. The Lancet 1998; 351:47-52.
  10. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stats Med 1984;3:409-420.

Search for citations for Dr. Yusuf on PubMed